In the first episode of Life Science Lab, host Ari Landon, PhD sits down with Alan Palkowitz, PhD, President and CEO of the Indiana Biosciences Research Institute (IBRI), to discuss how the IBRI is accelerating translational research and advancing new therapies through collaboration across the life sciences ecosystem. They explore what makes the IBRI model unique, the institute's scientific priorities, and what it takes to move discoveries toward real-world impact.

About the Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life. By connecting early-stage biotech companies with cutting-edge life science discoveries —and backed by the mission and resources of industry leaders, investors, and philanthropic partners— IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.

Learn more about the IBRI here: https://www.indianabiosciences.org/